Literature DB >> 27659912

Severe liver involvement in two patients with long-term history of fever: remember familial Mediterranean fever.

Nikolaos K Gatselis1, Panagiotis Skendros2, Konstantinos Ritis2, George N Dalekos1.   

Abstract

Familial Mediterranean fever (FMF) is characterised by recurrent, self-limited fever attacks and serositis. Severe liver involvement has rarely been reported. We present two FMF cases of a 55-year-old man and a 20-year-old woman in whom the prevailing manifestations were recurrent unexplained episodes of anicteric hepatitis (man) and recurrent severe jaundice (woman). A long-term history of recurrent self-limited episodes of fever was also claimed in both. After exclusion of infectious, malignant, autoimmune, and liver and biliary diseases, a diagnosis of FMF as confirmed by molecular analysis was established. The patients started colchicine 1 mg/day with immediate resolution of symptoms. During follow-up, no new episodes of fever and exacerbation of liver biochemical parameters have been recorded for 5 and 1 years. Physicians must keep FMF in mind in patients with recurrent episodes of unexplained severe liver impairment and fever and especially in regions like Mediterranean basin where hereditary periodic fever syndromes are common. 2016 BMJ Publishing Group Ltd.

Entities:  

Year:  2016        PMID: 27659912      PMCID: PMC5051369          DOI: 10.1136/bcr-2016-216941

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  27 in total

Review 1.  Review article: autoimmune hepatitis -- current management and challenges.

Authors:  K Zachou; P Muratori; G K Koukoulis; A Granito; N Gatselis; A Fabbri; G N Dalekos; L Muratori
Journal:  Aliment Pharmacol Ther       Date:  2013-09-08       Impact factor: 8.171

2.  Acute hepatitis in a child heterozygous for the I259V MEFV gene variant.

Authors:  Flora Tzifi; Philip Hawkins; Erato Atsali; Doxa Kotzia; Achilleas Attilakos
Journal:  Prague Med Rep       Date:  2014

3.  Clinical evaluation of R202Q alteration of MEFV genes in Turkish children.

Authors:  Elif Comak; Sema Akman; Mustafa Koyun; Cagla Serpil Dogan; Arife Uslu Gokceoglu; Yunus Arikan; Ibrahim Keser
Journal:  Clin Rheumatol       Date:  2014-04-10       Impact factor: 2.980

Review 4.  Inflammasomes in liver diseases.

Authors:  Gyongyi Szabo; Timea Csak
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

5.  Changes in the liver function tests during the attacks of familial Mediterranean fever.

Authors:  Cengiz Korkmaz; Timuçin Kaşifoğlu
Journal:  Rheumatol Int       Date:  2006-09-28       Impact factor: 2.631

6.  A novel mutation of the familial Mediterranean fever gene in a Greek family related to a non-classical, variably expressed FMF phenotype.

Authors:  Dimitrios Zonios; Clio P Mavragani; Stavros Giaglis; Konstatinos Ritis
Journal:  Rheumatol Int       Date:  2007-06-27       Impact factor: 2.631

7.  Interleukin-1 participates in the progression from liver injury to fibrosis.

Authors:  Roben G Gieling; Karen Wallace; Yuan-Ping Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

8.  Acute hepatitis in a patient with familial Mediterranean fever.

Authors:  Kiyoshi Migita; Seigo Abiru; Mototsugu Tanaka; Masahiro Ito; Taichiro Miyashita; Yumi Maeda; Tomohiro Koga; Minoru Nakamura; Atsumasa Komori; Hiroshi Yatsuhashi; Hiroaki Ida; Katsumi Eguchi; Kenji Hirayama; Michio Yasunami; Hiromi Ishibashi
Journal:  Liver Int       Date:  2007-10-25       Impact factor: 5.828

9.  Familial Mediterranean fever (FMF) mutations occur frequently in the Greek-Cypriot population of Cyprus.

Authors:  C Constantinou Deltas; Richard Mean; Elena Rossou; Constantina Costi; Panayiota Koupepidou; Irene Hadjiyanni; Victor Hadjiroussos; Petros Petrou; Alkis Pierides; Klea Lamnisou; Michael Koptides
Journal:  Genet Test       Date:  2002

10.  Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice.

Authors:  Elea Conrad; Theresa K Resch; Patricia Gogesch; Ulrich Kalinke; Ingo Bechmann; Christian Bogdan; Zoe Waibler
Journal:  Hepatology       Date:  2014-02-28       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.